from MarketResearch.com, are concise 15-30 page summaries
of popular full-length market research reports published by Kalorama Information. This MarketLooks report has been compiled from the following full-length study:
Title: The Worldwide Market for Prescription Dermatological Drugs
Published: April 2002
Each MarketLooks report includes top-level findings
from the respective parent report in a rich, easy to read format
accompanied by select charts and graphs
. Reports published prior to July 2001 are delivered in Powerpoint™. Reports published after July 2001 are delivered in Adobe PDF™ format. All are available via Instant Online Delivery to allow you to use the valuable information you've purchased immediately.
MarketLooks covering Kalorama Information studies are the perfect answer for:
The busy executive, researcher or product manager who needs top line statistics today in an easy to read, easy to digest format
The busy information professional who regularly juggles a multitude of basic requests for high-level market information from information patrons.
The consultant or analyst who needs to ramp up on a new market or demographic area quickly
Abstract from full report:
The Global Market for Prescription Dermatologic Drugs provides the reader with a comprehensive analysis of the domestic and international markets involving pharmaceuticals to treat skin diseases and disorders. Market information is available for the years 1996 to 2006, with the focus year 2001. Overview and product descriptions of general adjunctive therapy segments are covered, including:
- Drugs to treat Acne
- Drugs to treat Antiaging and Photodamage
- Drugs to treat Alopecia and Hair Removal
- Drugs to treat Fungal Infections
- Drugs to treat Inflammation and Psoriasis
- Miscellaneous drugs to treat other skin conditions
The study covers issues and trends affecting the market, research and developments, demographics and more. The study explores the current and potential effects of aging baby boomers on the prescription dermatology market and the continued demand for “lifestyle-type” drugs. Profiles of major market participants are included.